Conclusions: Tianhongye is safe and effective in treating stage diabetic foot.

结论: 天红液治疗早期糖尿病足安全、有效.

互联网

Conclusion: Batroxobin is effective medicine for cure diabetic foot.

结论: 东菱克栓酶是治疗糖尿病足有效药物.

互联网

HC Lam . Diabetic foot. KS - VGH Med News 2004; 7:1.

林兴中. 糖尿病足部病变. 高雄荣总医讯2004年; 第7卷第7期:第1页.

互联网

Non - type diabetic account 85 % of all patients. The treatment type should be clearing heat - toxicity , eliminating dampness.

非 缺血性的占糖尿病足总数的85%左右, 治疗应以清热解毒利湿为主.

互联网

OBJECTIVE : To evaluate the clinical effect of Kangfuxin plus Buflomedil hydrochloride on diabetic ulcer foot.

目的: 评价康复新液联合盐酸丁咯地尔注射液治疗糖尿病足溃疡的临床疗效.

互联网

Happen diabetic sufficient critical factor is fat it is to happen diabetic sufficient main factor.

发生糖尿病足的危险因素肥胖是发生糖尿病足的重要因素.

互联网

Objective To investigate pathogenic factors of diabetic foot and the effect of complex treatment.

目的探讨糖尿病足临床发病相关因素及综合治疗的疗效.

互联网

Purpose understanding old people is diabetic sufficient gangrenous ( DF ) clinical feature and its risk element.

目的了解老年人糖尿病足坏疽 ( DF ) 的临床特征及其危险因素.

互联网

Objective: to observe the clinical effect of Tianhongye on early stage diabetic foot.

目的: 观察天红液治疗早期糖尿病足的临床疗效.

互联网

Objective : To explore the surgical treatment for diabetic foot ulcers and reduce its level amputation rate.

目的: 探讨外科治疗糖尿病足部溃疡以降低其高位截肢率的措施.

互联网